ITI Pharma and Healthcare Fund Regular Growth
3Y Annualised
17.37%
-1.24% 1D
Fund Performance
Fund Multiplier
Fund Info
Peer Comparison
Fund Managers
AMC Details
Performance
Annualised
-7.02%
-1.24% 1D
Benchmark
N/A
Fund Multiplier
Time it would have taken to make your money double (2x), quadruple (4x) and quintuple (5x)
4 years 4 months
6 years 4 months
9 years 7 months
Fund info
Fund size
₹216.51 Cr
Min. SIP amount
₹500
Min. Lumpsum amount
₹5000
Exit load
0.01%
1% - If redeemed or switched out on or before completion of 12 months from the date of allotment of units. Nil - If redeemed or switched out after completion of 12 months from the date of allotment of units.
Risk Profile
Very High Risk
This Fund's Performance Compared With Peers
Over the Period of oneMonth
1st
Nippon India Pharma Fund - Direct Plan - Bonus Plan
2nd
Nippon India Pharma Fund - Direct Plan - Growth Plan
3rd
Nippon India Pharma Fund - Bonus
4th
Nippon India Pharma Fund - Growth
5th
Aditya Birla Sun Life Pharma & Healthcare Fund Direct Reinvestment Inc Dist cum Cap Wdrl
76th
ITI Pharma and Healthcare Fund Regular Growth
Fund Managers
About ITI Pharma and Healthcare Fund Regular Growth
ITI Pharma and Healthcare Fund Regular Growth is a Equity mutual fund scheme from ITI Asset Management Limited. This fund has been in existence for 3 years, having been launched on 2021-11-11. ITI Pharma and Healthcare Fund Regular Growth has ₹216.51 Cr worth of assets under management (AUM) as of Wed Mar 12 2025. The latest Net Asset Value (NAV) of ITI Pharma and Healthcare Fund Regular Growth as of Tue Mar 11 2025 is ₹14.9067. The fund has an expense ratio of 2.25%, which is medium comparable to most other Equity funds.
ITI Pharma and Healthcare Fund Regular Growth returns for the last 1 year are 10.52%. Since launch, it has delivered 12.59% average annual returns.
The ITI Pharma and Healthcare Fund Regular Growth has the majority of its money invested in Healthcare sectors.
Top 5 Holdings of ITI Pharma and Healthcare Fund Regular Growth.
- Sun Pharmaceuticals Industries Ltd: 16.00%
- Lupin Ltd: 6.34%
- Apollo Hospitals Enterprise Ltd: 5.03%
- Divi's Laboratories Ltd: 4.89%
- Suven Pharmaceuticals Ltd: 4.88%
AMC Information
Name | ITI Asset Management Limited |
---|---|
Founding Date | 2021-11-11 |
mfassist@itiorg.com | |
Phone | 022-66214999 |
Website | www.itimf.com |
Address | Naman Midtown “A” Wing, 21st Floor, Senapati Bapat Marg, Elphinstone Road |
Tax Implications of ITI Pharma and Healthcare Fund Regular Growth
Short Term Gains | 20% + applicable Surcharge + 4% Cess |
---|---|
Long Term Gains | 12.5% without indexation + applicable Surcharge + 4% Cess |
Similar Funds from ITI Asset Management Limited

AlternativeArbitrage Fund
3Y CAGR
5.68%
expense ratio
0.92%
fund size
₹43.18 Cr

AlternativeArbitrage Fund
3Y CAGR
6.48%
expense ratio
0.20%
fund size
₹43.18 Cr

Money MarketLiquid
3Y CAGR
6.30%
expense ratio
0.25%
fund size
₹50.86 Cr

Money MarketLiquid
3Y CAGR
6.46%
expense ratio
0.09%
fund size
₹50.86 Cr

EquityMulti-Cap
3Y CAGR
18.72%
expense ratio
0.18%
fund size
₹1312.94 Cr
FAQs
What is the current NAV of ITI Pharma and Healthcare Fund Regular Growth?

What are the average returns of ITI Pharma and Healthcare Fund Regular Growth?

How do I invest in ITI Pharma and Healthcare Fund Regular Growth?

What is the expense ratio of ITI Pharma and Healthcare Fund Regular Growth?

What are net assets under management (AUM) of ITI Pharma and Healthcare Fund Regular Growth?

What is the PE and PB ratio of ITI Pharma and Healthcare Fund Regular Growth?

What are the top 5 holdings of ITI Pharma and Healthcare Fund Regular Growth?

What are the top 3 sectors that ITI Pharma and Healthcare Fund Regular Growth has invested in?

Who is the manager of ITI Pharma and Healthcare Fund Regular Growth?

What is the exit load of ITI Pharma and Healthcare Fund Regular Growth?

How to Redeem ITI Pharma and Healthcare Fund Regular Growth?

Can I invest in SIP and a Lump Sum of ITI Pharma and Healthcare Fund Regular Growth?
